Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1995 May 1;181(5):1835–1845. doi: 10.1084/jem.181.5.1835

HLA DRB4 0101-restricted immunodominant T cell autoepitope of pyruvate dehydrogenase complex in primary biliary cirrhosis: evidence of molecular mimicry in human autoimmune diseases

PMCID: PMC2191998  PMID: 7536796

Abstract

We established six T cell clones specific for pyruvate dehydrogenase complex (PDC)-E2 peptides from four different patients with primary biliary cirrhosis using 33 different peptides of 17-20 amino acid residues corresponding to human PDC-E2 as stimulating antigens. The minimal T cell epitopes of these six T cell clones were all mapped to the same region of the PDC-E2 peptide 163-176 (GDLLAEIETDKATI), which corresponds to the inner lipoyl domain of PDC-E2. The HLA restriction molecules for this epitope were all identified as HLA DRB4 0101. The common essential amino acids of this epitope for these T cell clones were E, D, and K at positions 170, 172, and 173, respectively; other crucial amino acids for this epitope differed in each T cell clone. In addition, the alanine-substituted peptides at positions 170 and 173, but not 172, inhibited the proliferation of all T cell clones induced by the original peptide of human PDC-E2 163-176, indicating that amino acid D at position 172 is a critical MHC-binding site for all T cell clones tested. Interestingly, all T cell clones reacted to PDC-E2 peptide 36-49 (GDLIAEVETDKATV), which corresponds to the outer lipoyl domain of human PDC-E2. Furthermore, one T cell clone cross-reacted with exogenous antigens such as Escherichia coli PDC-E2 peptide 31- 44/134-147/235-248 (EQSLITVEGDKASM), which has an EXDK sequence. This is a definite demonstration of the presence of molecular mimicry at the T cell clonal level in human autoimmune diseases. It is also considered possible to design peptide-specific immunotherapy based on the findings of T cell autoepitopes in primary biliary cirrhosis.

Full Text

The Full Text of this article is available as a PDF (1.1 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahlers J. D., Pendleton C. D., Dunlop N., Minassian A., Nara P. L., Berzofsky J. A. Construction of an HIV-1 peptide vaccine containing a multideterminant helper peptide linked to a V3 loop peptide 18 inducing strong neutralizing antibody responses in mice of multiple MHC haplotypes after two immunizations. J Immunol. 1993 Jun 15;150(12):5647–5665. [PubMed] [Google Scholar]
  2. Baba E., Nakamura M., Ohkuma K., Kira J., Tanaka Y., Nakano S., Niho Y. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies. J Immunol. 1995 Jan 1;154(1):399–412. [PubMed] [Google Scholar]
  3. Ballardini G., Mirakian R., Bianchi F. B., Pisi E., Doniach D., Bottazzo G. F. Aberrant expression of HLA-DR antigens on bileduct epithelium in primary biliary cirrhosis: relevance to pathogenesis. Lancet. 1984 Nov 3;2(8410):1009–1013. doi: 10.1016/s0140-6736(84)91108-5. [DOI] [PubMed] [Google Scholar]
  4. Bassendine M. F., Dewar P. J., James O. F. HLA-DR antigens in primary biliary cirrhosis: lack of association. Gut. 1985 Jun;26(6):625–628. doi: 10.1136/gut.26.6.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Berzofsky J. A., Cease K. B., Cornette J. L., Spouge J. L., Margalit H., Berkower I. J., Good M. F., Miller L. H., DeLisi C. Protein antigenic structures recognized by T cells: potential applications to vaccine design. Immunol Rev. 1987 Aug;98:9–52. doi: 10.1111/j.1600-065x.1987.tb00518.x. [DOI] [PubMed] [Google Scholar]
  6. Björkland A., Festin R., Mendel-Hartvig I., Nyberg A., Löf L., Tötterman T. H. Blood and liver-infiltrating lymphocytes in primary biliary cirrhosis: increase in activated T and natural killer cells and recruitment of primed memory T cells. Hepatology. 1991 Jun;13(6):1106–1111. doi: 10.1002/hep.1840130617. [DOI] [PubMed] [Google Scholar]
  7. Burroughs A. K., Butler P., Sternberg M. J., Baum H. Molecular mimicry in liver disease. Nature. 1992 Jul 30;358(6385):377–378. doi: 10.1038/358377a0. [DOI] [PubMed] [Google Scholar]
  8. Champion B. R., Page K. R., Parish N., Rayner D. C., Dawe K., Biswas-Hughes G., Cooke A., Geysen M., Roitt I. M. Identification of a thyroxine-containing self-epitope of thyroglobulin which triggers thyroid autoreactive T cells. J Exp Med. 1991 Aug 1;174(2):363–370. doi: 10.1084/jem.174.2.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Chicz R. M., Urban R. G., Gorga J. C., Vignali D. A., Lane W. S., Strominger J. L. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med. 1993 Jul 1;178(1):27–47. doi: 10.1084/jem.178.1.27. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Coppel R. L., McNeilage L. J., Surh C. D., Van de Water J., Spithill T. W., Whittingham S., Gershwin M. E. Primary structure of the human M2 mitochondrial autoantigen of primary biliary cirrhosis: dihydrolipoamide acetyltransferase. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7317–7321. doi: 10.1073/pnas.85.19.7317. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Dayan C. M., Londei M., Corcoran A. E., Grubeck-Loebenstein B., James R. F., Rapoport B., Feldmann M. Autoantigen recognition by thyroid-infiltrating T cells in Graves disease. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7415–7419. doi: 10.1073/pnas.88.16.7415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Ercilla G., Parés A., Arriaga F., Bruguera M., Castillo R., Rodés J., Vives J. Primary biliary cirrhosis associated with HLA-DRw3. Tissue Antigens. 1979 Nov;14(5):449–452. doi: 10.1111/j.1399-0039.1979.tb00874.x. [DOI] [PubMed] [Google Scholar]
  13. Fujinami R. S., Oldstone M. B. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity. Science. 1985 Nov 29;230(4729):1043–1045. doi: 10.1126/science.2414848. [DOI] [PubMed] [Google Scholar]
  14. Fussey S. P., Ali S. T., Guest J. R., James O. F., Bassendine M. F., Yeaman S. J. Reactivity of primary biliary cirrhosis sera with Escherichia coli dihydrolipoamide acetyltransferase (E2p): characterization of the main immunogenic region. Proc Natl Acad Sci U S A. 1990 May;87(10):3987–3991. doi: 10.1073/pnas.87.10.3987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fussey S. P., Guest J. R., James O. F., Bassendine M. F., Yeaman S. J. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc Natl Acad Sci U S A. 1988 Nov;85(22):8654–8658. doi: 10.1073/pnas.85.22.8654. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gautam A. M., Pearson C. I., Smilek D. E., Steinman L., McDevitt H. O. A polyalanine peptide with only five native myelin basic protein residues induces autoimmune encephalomyelitis. J Exp Med. 1992 Aug 1;176(2):605–609. doi: 10.1084/jem.176.2.605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Germain R. N., Margulies D. H. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol. 1993;11:403–450. doi: 10.1146/annurev.iy.11.040193.002155. [DOI] [PubMed] [Google Scholar]
  18. Gershwin M. E., Mackay I. R., Sturgess A., Coppel R. L. Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol. 1987 May 15;138(10):3525–3531. [PubMed] [Google Scholar]
  19. Graham S., Wang E. C., Jenkins O., Borysiewicz L. K. Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus. J Virol. 1993 Mar;67(3):1627–1637. doi: 10.1128/jvi.67.3.1627-1637.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hammer J., Takacs B., Sinigaglia F. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries. J Exp Med. 1992 Oct 1;176(4):1007–1013. doi: 10.1084/jem.176.4.1007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hammer J., Valsasnini P., Tolba K., Bolin D., Higelin J., Takacs B., Sinigaglia F. Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell. 1993 Jul 16;74(1):197–203. doi: 10.1016/0092-8674(93)90306-b. [DOI] [PubMed] [Google Scholar]
  22. Hoffmann R. M., Pape G. R., Spengler U., Rieber E. P., Eisenburg J., Döhrmann J., Paumgartner G., Riethmüller G. Clonal analysis of liver-derived T cells of patients with primary biliary cirrhosis. Clin Exp Immunol. 1989 May;76(2):210–215. [PMC free article] [PubMed] [Google Scholar]
  23. Honeyman M. C., Cram D. S., Harrison L. C. Glutamic acid decarboxylase 67-reactive T cells: a marker of insulin-dependent diabetes. J Exp Med. 1993 Feb 1;177(2):535–540. doi: 10.1084/jem.177.2.535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hutchings P. R., Cooke A., Dawe K., Champion B. R., Geysen M., Valerio R., Roitt I. M. A thyroxine-containing peptide can induce murine experimental autoimmune thyroiditis. J Exp Med. 1992 Mar 1;175(3):869–872. doi: 10.1084/jem.175.3.869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Johnston D. E., Kaplan M. M., Miller K. B., Connors C. M., Milford E. L. Histocompatibility antigens in primary biliary cirrhosis. Am J Gastroenterol. 1987 Nov;82(11):1127–1129. [PubMed] [Google Scholar]
  26. Joplin R., Lindsay J. G., Hubscher S. G., Johnson G. D., Shaw J. C., Strain A. J., Neuberger J. M. Distribution of dihydrolipoamide acetyltransferase (E2) in the liver and portal lymph nodes of patients with primary biliary cirrhosis: an immunohistochemical study. Hepatology. 1991 Sep;14(3):442–447. [PubMed] [Google Scholar]
  27. Jorgensen J. L., Reay P. A., Ehrich E. W., Davis M. M. Molecular components of T-cell recognition. Annu Rev Immunol. 1992;10:835–873. doi: 10.1146/annurev.iy.10.040192.004155. [DOI] [PubMed] [Google Scholar]
  28. Kaplan M. M. Primary biliary cirrhosis. N Engl J Med. 1987 Feb 26;316(9):521–528. doi: 10.1056/NEJM198702263160907. [DOI] [PubMed] [Google Scholar]
  29. Krams S. M., Van de Water J., Coppel R. L., Esquivel C., Roberts J., Ansari A., Gershwin M. E. Analysis of hepatic T lymphocyte and immunoglobulin deposits in patients with primary biliary cirrhosis. Hepatology. 1990 Aug;12(2):306–313. doi: 10.1002/hep.1840120219. [DOI] [PubMed] [Google Scholar]
  30. Kropshofer H., Max H., Müller C. A., Hesse F., Stevanovic S., Jung G., Kalbacher H. Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif. J Exp Med. 1992 Jun 1;175(6):1799–1803. doi: 10.1084/jem.175.6.1799. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Lehmann P. V., Forsthuber T., Miller A., Sercarz E. E. Spreading of T-cell autoimmunity to cryptic determinants of an autoantigen. Nature. 1992 Jul 9;358(6382):155–157. doi: 10.1038/358155a0. [DOI] [PubMed] [Google Scholar]
  32. Lohmann T., Leslie R. D., Hawa M., Geysen M., Rodda S., Londei M. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet. 1994 Jun 25;343(8913):1607–1608. doi: 10.1016/s0140-6736(94)93061-9. [DOI] [PubMed] [Google Scholar]
  33. Londei M., Bottazzo G. F., Feldmann M. Human T-cell clones from autoimmune thyroid glands: specific recognition of autologous thyroid cells. Science. 1985 Apr 5;228(4695):85–89. doi: 10.1126/science.3871967. [DOI] [PubMed] [Google Scholar]
  34. Luo A. M., Garza K. M., Hunt D., Tung K. S. Antigen mimicry in autoimmune disease sharing of amino acid residues critical for pathogenic T cell activation. J Clin Invest. 1993 Nov;92(5):2117–2123. doi: 10.1172/JCI116812. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Löhr H., Fleischer B., Gerken G., Yeaman S. J., Meyer zum Büschenfelde K. H., Manns M. Autoreactive liver-infiltrating T cells in primary biliary cirrhosis recognize inner mitochondrial epitopes and the pyruvate dehydrogenase complex. J Hepatol. 1993 Jul;18(3):322–327. doi: 10.1016/s0168-8278(05)80276-4. [DOI] [PubMed] [Google Scholar]
  36. Manfredi A. A., Yuen M. H., Moiola L., Protti M. P., Conti-Tronconi B. M. Human acetylcholine receptor presentation in myasthenia gravis. DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules. J Immunol. 1994 Apr 15;152(8):4165–4174. [PubMed] [Google Scholar]
  37. Martin R., Howell M. D., Jaraquemada D., Flerlage M., Richert J., Brostoff S., Long E. O., McFarlin D. E., McFarland H. F. A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med. 1991 Jan 1;173(1):19–24. doi: 10.1084/jem.173.1.19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Martin R., Utz U., Coligan J. E., Richert J. R., Flerlage M., Robinson E., Stone R., Biddison W. E., McFarlin D. E., McFarland H. F. Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J Immunol. 1992 Mar 1;148(5):1359–1366. [PubMed] [Google Scholar]
  39. Matsui M., Nakamura M., Ishibashi H., Koike K., Kudo J., Niho Y. Human monoclonal antibodies from a patient with primary biliary cirrhosis that recognize two distinct autoepitopes in the E2 component of the pyruvate dehydrogenase complex. Hepatology. 1993 Nov;18(5):1069–1077. [PubMed] [Google Scholar]
  40. Matsushita S., Takahashi K., Motoki M., Komoriya K., Ikagawa S., Nishimura Y. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J Exp Med. 1994 Sep 1;180(3):873–883. doi: 10.1084/jem.180.3.873. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Meuer S. C., Moebius U., Manns M. M., Dienes H. P., Ramadori G., Hess G., Hercend T., Meyer zum Büschenfelde K. H. Clonal analysis of human T lymphocytes infiltrating the liver in chronic active hepatitis B and primary biliary cirrhosis. Eur J Immunol. 1988 Sep;18(9):1447–1452. doi: 10.1002/eji.1830180922. [DOI] [PubMed] [Google Scholar]
  42. Miyamori H., Kato Y., Kobayashi K., Hattori N. HLA antigens in Japanese patients with primary biliary cirrhosis and autoimmune hepatitis. Digestion. 1983;26(4):213–217. doi: 10.1159/000198892. [DOI] [PubMed] [Google Scholar]
  43. Mohan C., Adams S., Stanik V., Datta S. K. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus. J Exp Med. 1993 May 1;177(5):1367–1381. doi: 10.1084/jem.177.5.1367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Moiola L., Karachunski P., Protti M. P., Howard J. F., Jr, Conti-Tronconi B. M. Epitopes on the beta subunit of human muscle acetylcholine receptor recognized by CD4+ cells of myasthenia gravis patients and healthy subjects. J Clin Invest. 1994 Mar;93(3):1020–1028. doi: 10.1172/JCI117050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Moiola L., Protti M. P., McCormick D., Howard J. F., Conti-Tronconi B. M. Myasthenia gravis. Residues of the alpha and gamma subunits of muscle acetylcholine receptor involved in formation of immunodominant CD4+ epitopes. J Immunol. 1994 May 1;152(9):4686–4698. [PubMed] [Google Scholar]
  46. Nakanuma Y. Distribution of B lymphocytes in nonsuppurative cholangitis in primary biliary cirrhosis. Hepatology. 1993 Sep;18(3):570–575. [PubMed] [Google Scholar]
  47. Nickowitz R. E., Worman H. J. Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210. J Exp Med. 1993 Dec 1;178(6):2237–2242. doi: 10.1084/jem.178.6.2237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Ohta Y. Report of the research subgroup of autoimmune hepatitis/primary biliary cirrhosis. Gastroenterol Jpn. 1993 Mar;28 (Suppl 4):128–133. doi: 10.1007/BF02782905. [DOI] [PubMed] [Google Scholar]
  49. Okubo M., Yamamoto K., Kato T., Matsuura N., Nishimaki T., Kasukawa R., Ito K., Mizushima Y., Nishioka K. Detection and epitope analysis of autoantigen-reactive T cells to the U1-small nuclear ribonucleoprotein A protein in autoimmune disease patients. J Immunol. 1993 Jul 15;151(2):1108–1115. [PubMed] [Google Scholar]
  50. Oldstone M. B. Molecular mimicry and autoimmune disease. Cell. 1987 Sep 11;50(6):819–820. doi: 10.1016/0092-8674(87)90507-1. [DOI] [PubMed] [Google Scholar]
  51. Ota K., Matsui M., Milford E. L., Mackin G. A., Weiner H. L., Hafler D. A. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature. 1990 Jul 12;346(6280):183–187. doi: 10.1038/346183a0. [DOI] [PubMed] [Google Scholar]
  52. Palker T. J., Matthews T. J., Langlois A., Tanner M. E., Martin M. E., Scearce R. M., Kim J. E., Berzofsky J. A., Bolognesi D. P., Haynes B. F. Polyvalent human immunodeficiency virus synthetic immunogen comprised of envelope gp120 T helper cell sites and B cell neutralization epitopes. J Immunol. 1989 May 15;142(10):3612–3619. [PubMed] [Google Scholar]
  53. Prochazka E. J., Terasaki P. I., Park M. S., Goldstein L. I., Busuttil R. W. Association of primary sclerosing cholangitis with HLA-DRw52a. N Engl J Med. 1990 Jun 28;322(26):1842–1844. doi: 10.1056/NEJM199006283222603. [DOI] [PubMed] [Google Scholar]
  54. Protti M. P., Manfredi A. A., Horton R. M., Bellone M., Conti-Tronconi B. M. Myasthenia gravis: recognition of a human autoantigen at the molecular level. Immunol Today. 1993 Jul;14(7):363–368. doi: 10.1016/0167-5699(93)90237-F. [DOI] [PubMed] [Google Scholar]
  55. Seki T., Kiyosawa K., Ota M., Furuta S., Fukushima H., Tanaka E., Yoshizawa K., Kumagai T., Mizuki N., Ando A. Association of primary biliary cirrhosis with human leukocyte antigen DPB1*0501 in Japanese patients. Hepatology. 1993 Jul;18(1):73–78. [PubMed] [Google Scholar]
  56. Spengler U., Pape G. R., Hoffmann R. M., Johnson J. P., Eisenburg J., Paumgartner G., Riethmüller G. Differential expression of MHC class II subregion products on bile duct epithelial cells and hepatocytes in patients with primary biliary cirrhosis. Hepatology. 1988 May-Jun;8(3):459–462. doi: 10.1002/hep.1840080304. [DOI] [PubMed] [Google Scholar]
  57. Stern L. J., Brown J. H., Jardetzky T. S., Gorga J. C., Urban R. G., Strominger J. L., Wiley D. C. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 1994 Mar 17;368(6468):215–221. doi: 10.1038/368215a0. [DOI] [PubMed] [Google Scholar]
  58. Van de Water J., Ansari A. A., Surh C. D., Coppel R., Roche T., Bonkovsky H., Kaplan M., Gershwin M. E. Evidence for the targeting by 2-oxo-dehydrogenase enzymes in the T cell response of primary biliary cirrhosis. J Immunol. 1991 Jan 1;146(1):89–94. [PubMed] [Google Scholar]
  59. Van de Water J., Gershwin M. E., Leung P., Ansari A., Coppel R. L. The autoepitope of the 74-kD mitochondrial autoantigen of primary biliary cirrhosis corresponds to the functional site of dihydrolipoamide acetyltransferase. J Exp Med. 1988 Jun 1;167(6):1791–1799. doi: 10.1084/jem.167.6.1791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Van de Water J., Turchany J., Leung P. S., Lake J., Munoz S., Surh C. D., Coppel R., Ansari A., Nakanuma Y., Gershwin M. E. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2. J Clin Invest. 1993 Jun;91(6):2653–2664. doi: 10.1172/JCI116504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Wraith D. C., Bruun B., Fairchild P. J. Cross-reactive antigen recognition by an encephalitogenic T cell receptor. Implications for T cell biology and autoimmunity. J Immunol. 1992 Dec 1;149(11):3765–3770. [PubMed] [Google Scholar]
  62. Wucherpfennig K. W., Sette A., Southwood S., Oseroff C., Matsui M., Strominger J. L., Hafler D. A. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J Exp Med. 1994 Jan 1;179(1):279–290. doi: 10.1084/jem.179.1.279. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Yeaman S. J., Fussey S. P., Danner D. J., James O. F., Mutimer D. J., Bassendine M. F. Primary biliary cirrhosis: identification of two major M2 mitochondrial autoantigens. Lancet. 1988 May 14;1(8594):1067–1070. doi: 10.1016/s0140-6736(88)91894-6. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES